Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Genentech gets FDA priority review for two cancer drugs

pharmaceutical-technologyFebruary 20, 2019

Tag: Genentech , FDA , entrectinib

PharmaSources Customer Service